Thyroid Medication Recalled Nationwide Due to Possible 'Superpotency' Issue
The company said 3,600 units were released and about 1,900 were sold before testing found the tablets could be stronger than intended.
- On Monday, Vitruvias Therapeutics Inc. initiated a consumer-level recall of one lot of its 30 mg Thyroid Tablets, USP after testing confirmed the product could be superpotent, or stronger than intended.
- Testing revealed the tablets are stronger than intended, potentially causing weight loss, heat intolerance, fatigue, and hypertension for those consuming the medication.
- Distributed nationwide between Jan. 31 and Sept. 30, 2025, the affected batch includes 3,600 units with about 1,900 sold; identify them by National Drug Code 69680-166-00 or lot 504950.
- The FDA notice advises patients currently taking the recalled tablets not to stop without contacting their health care provider; Vitruvias Therapeutics has received no reports of adverse events.
- Consumers with questions can contact Vitruvias Therapeutics Inc. by phone at 256-239-9373 or email at safety@vitruvias.com, as affected products expire Sept. 30, 2026.
54 Articles
54 Articles
FDA Recalls Thyroid Tablets Over “Superpotency”
NewsNation reports: Vitruvias Therapeutics is voluntarily recalling one lot of thyroid tablets because they could potentially be “superpotent,” federal regulators announced this week. The high potency 30mg tablets could cause hyperthyroidism, or an overactive thyroid, according to the Food and Drug Administration. The affected lot (504950) was distributed nationwide to Vitruvias Therapeutics’ direct accounts from Jan. 31 to Sept. 30, 2025. Consu…
The Oregonian
‘Superpotent’ thyroid medication recalled as batch could cause serious health problems
A single lot of a popular thyroid medication is being recalled after testing showed the batch may be superpotent. According to the Food & Drug Administration, the recall applies to Thyroid Tablets, USP 30 mg produced by Alabama-based Vitruvias Therapeutics Inc.
Fox Business
The New York LedgerThyroid medication recalled nationwide after tablets found to be 'superpotent': FDA
Open the article to view the coverage from Fox Business
Coverage Details
Bias Distribution
- 76% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
